AngioDynamics (ANGO) Tops Q1 Views; Raises FY10 Outlook
More News related to ANGO
- AngioDynamics to Participate in the 21st Annual Piper Jaffray Health Care Conference
- AngioDynamics Appoints Stephen McGill as Senior Vice President and General Manager, International
- AngioDynamics (ANGO) Tops Q1 Views; Raises FY10 Outlook
- AngioDynamics Reports Fiscal First Quarter 2010 Financial Results
- Trading Radar for 10/06: Yum! (YUM), Pepsi Bottling (PBG), Chattem (CHTT), AngioDynamics (ANGO) Report
More News related to Earnings
- Maxim Group Initiates Coverage on Golden Green Enterprises (CHOP) with a Buy
- Hilliard Lyons Initiates Coveage on Approach Resources (AREX) with a Buy
- Wells Fargo Transfers Coverage on Intuitive Surgical (ISRG) to a Market Perform; Raises Valuation Range
- Wedbush Initiates Coverage on Coinstar (CSTR) with an Outperform
- Thomas Weisel Starts FARO Tech. (FARO) at Overweight, $24 Price Target
AngioDynamics (Nasdaq: ANGO) reports Q1 EPS of $0.09, 1 cent better than the analyst estimate of $0.08. Revenue for the quarter was $50.1 million, which compares to the estimate of $47.79 million.
Raises FY10 sales guidance from $209-$215 million to $211-$215 million, which compares to the Street estimate of $209.92 million. FY10 EPS move to $0.45-$0.47, versus the consensus of $0.45.
Related Categories
EarningsGuidance
Hot List
Stocks Mentioned
-0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
